Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001354488-12-002281
Filing Date
2012-05-10
Accepted
2012-05-10 15:10:30
Documents
18
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT tdlp_10q.htm 10-Q 778952
2 AMENDED AND RESTATED CERTIFICATE tdlp_ex31.htm EX-3.1 13502
3 WAIVER AND SETTLEMENT AGREEMENT tdlp_ex101.htm EX-10.1 40457
4 WAIVER AND SETTLEMENT AGREEMENT tdlp_ex102.htm EX-10.2 42848
5 SENIOR ADVISORY AGREEMENT tdlp_ex103.htm EX-10.3 108567
6 EMPLOYMENT AGREEMENT tdlp_ex104.htm EX-10.4 178993
7 EMPLOYMENT AGREEMENT tdlp_ex105.htm EX-10.5 168378
8 EMPLOYMENT AGREEMENT tdlp_ex106.htm EX-10.6 168197
9 CERTIFICATION tdlp_ex311.htm EX-31.1 18860
10 CERTIFICATION tdlp_ex312.htm EX-31.2 19036
11 CERTIFICATION tdlp_ex321.htm EX-32.1 8047
12 CERTIFICATION tdlp_ex322.htm EX-32.2 8075
  Complete submission text file 0001354488-12-002281.txt   2882933

Data Files

Seq Description Document Type Size
13 immy-20120331.xml EX-101.INS 210372
14 immy-20120331.xsd EX-101.SCH 11023
15 immy-20120331_cal.xml EX-101.CAL 31599
16 immy-20120331_def.xml EX-101.DEF 6406
17 immy-20120331_lab.xml EX-101.LAB 87254
18 immy-20120331_pre.xml EX-101.PRE 61687
Mailing Address 437 S. HWY 101 STE 209 SOLANA BEACH CA 92075
Business Address 437 S. HWY 101 STE 209 SOLANA BEACH CA 92075 858-433-2800
Imprimis Pharmaceuticals, Inc. (Filer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52998 | Film No.: 12829827
SIC: 2834 Pharmaceutical Preparations